Academic background&position
data loading...
Major papers
1. [SCIE] Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies [MOLECULAR NEURODEGENERATION] - 2024-10-19
2. [SCIE] Tau acetylation at K280 regulates tau phosphorylation [INTERNATIONAL JOURNAL OF NEUROSCIENCE] - 2023-12-01
3. [SCIE] Amphiregulin normalizes altered circuit connectivity for social dominance of the CRTC3 knockout mouse [MOLECULAR PSYCHIATRY] - 2023-11-01
4. [SCIE] Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease [Cell and Bioscience] - 2023-09-29
5. [SCIE] Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models [JOURNAL OF CLINICAL INVESTIGATION] - 2023-04-17
Offices
Dementia Biopharmaceuticals Development Department
Our lab develops biopharmaceuticals such as antibodies and peptides for the treatment and diagnosis of Alzheimer's disease.
From basic research on neuroscience to the development of treatment for neurological diseases,
we hope that many students who want to maximize their abilities will apply to our lab.
Faculty/Research
